<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyDrugSummaryOutput xmlns:ns2="local" id="107955" name="R-4329"><HDS>Discovery</HDS><Actions><Action id="59620" type="secondary">Unspecified drug target</Action><Action id="1594" type="secondary">Antibacterial</Action><Action id="393" type="secondary">Immunostimulant</Action><Action id="173474" type="secondary">Microbiome modulator</Action></Actions><Indications><Indication id="995" type="primary">Clostridium difficile infection</Indication></Indications><Entities><Entity>Biological</Entity></Entities><OriginatorCompany id="1148669">Rise Therapeutics LLC</OriginatorCompany></ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyDrugSummaryOutput>